NasdaqGS - Nasdaq Real Time Price USD
Cogent Biosciences, Inc. (COGT)
At close: October 18 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-177,271.00
-153,624.00
-118,638.00
-58,763.00
-35,850.00
--
Investing Cash Flow
-163,628.00
-97,824.00
-124,718.00
-1,719.00
8,420.00
--
Financing Cash Flow
214,801.00
163,536.00
163,558.00
37,976.00
232,196.00
--
End Cash Position
88,219.00
53,229.00
141,141.00
220,939.00
243,445.00
--
Capital Expenditure
-654.00
-2,796.00
-6,863.00
-1,719.00
--
-33.00
Issuance of Capital Stock
213,166.00
161,819.00
161,945.00
38,006.00
231,636.00
--
Free Cash Flow
-177,925.00
-156,420.00
-125,501.00
-60,482.00
-35,850.00
--
12/31/2019 - 3/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DNTH Dianthus Therapeutics, Inc.
29.05
+3.64%
SYRE Spyre Therapeutics, Inc.
32.76
0.00%
IRON Disc Medicine, Inc.
50.56
+0.14%
VRDN Viridian Therapeutics, Inc.
24.98
+2.97%
CGEM Cullinan Therapeutics, Inc.
16.77
-3.45%
AVTE Aerovate Therapeutics, Inc.
2.3700
+2.16%
CRGX CARGO Therapeutics, Inc.
22.22
+2.40%
STOK Stoke Therapeutics, Inc.
13.00
-2.03%
PEPG PepGen Inc.
8.94
+0.79%
PTGX Protagonist Therapeutics, Inc.
46.97
-0.11%